| 心脑宁胶囊治疗动脉粥样硬化性心血管疾病临床应用专家共识 |
| |
| 引用本文： | 陆峰,胡元会,陈志刚,卢健棋,戴小华,符德玉,苗华为,陈明,周卫东,韩祖成,杨东东,王振涛,杜廷海,杨锡燕,陈颖,张艳,白雪,许滔,徐浩,王永霞,王佑华,王庆高,褚瑜光,何志义,田颖,陆芳,伊博文.心脑宁胶囊治疗动脉粥样硬化性心血管疾病临床应用专家共识[J].中草药,2020,51(11):2863-2870. |
| |
| 作者姓名： | 陆峰 胡元会 陈志刚 卢健棋 戴小华 符德玉 苗华为 陈明 周卫东 韩祖成 杨东东 王振涛 杜廷海 杨锡燕 陈颖 张艳 白雪 许滔 徐浩 王永霞 王佑华 王庆高 褚瑜光 何志义 田颖 陆芳 伊博文 |
| |
| 作者单位： | 山东中医药大学附属医院心内科 国家中医临床研究基地, 山东 济南 250014;中国中医科学院广安门医院, 北京 100053;北京中医药大学东方医院, 北京 100078;广西中医药大学第一附属医院, 广西 南宁 530023;安徽中医药大学第一附属医院, 安徽 合肥 230031;上海中医药大学附属岳阳中西医结合医院, 上海 200437;河北省中医院, 河北 石家庄 050011;重庆医科大学附属第一医院, 重庆 400042;煤炭总医院, 北京 100028;陕西省中医医院, 陕西 西安 710003;成都中医药大学附属医院, 四川 成都 610072;河南省中医院, 河南 郑州 453003;河南中医药大学第一附属医院, 河南 郑州 450099;天津中医药大学第一附属医院, 天津 300193;长春中医药大学附属医院, 吉林 长春 130021;辽宁中医药大学附属医院, 辽宁 沈阳 110032;西南医科大学附属中医医院, 四川 泸州 646699;贵州中医药大学第二附属医院, 贵州 贵阳 550003;中国中医科学院西苑医院, 北京 100091;上海中医药大学附属龙华医院, 上海 200126;中国医科大学附属第一医院, 辽宁 沈阳 110122 |
| |
| 基金项目： | 国家重点研发计划中医药现代化研究2018年度重点专项（2018YFC1707402） |
| |
| 摘 要： | 本共识建立了成人动脉粥样硬化性心血管疾病(atherosclerotic cardiovascular disease,ASCVD)高危人群规范应用心脑宁胶囊以提升疗效的关键流程,概述了心脑宁胶囊的中医配伍理论、药学和药理研究特性,界定了心脑宁胶囊的精确适用人群、干预时机、病证疗效特点及优选应用方案,归纳了心脑宁胶囊的不良反应、使用禁忌、注意事项及非临床安全性等相关证据。本共识适合ASCVD相关专业领域的执业医师、执业中医医师和执业中西医结合医师使用。
|
| 关 键 词： | 心脑宁胶囊 动脉粥样硬化性心血管疾病 气滞血瘀证 行气活血 专家共识 |
| 收稿时间： | 2020/5/14 0:00:00 |
Experts consensus statement on Xinnaoning Capsule in clinical practice of atherosclerotic cardiovascular disease |
| |
| LU Feng,HU Yuan-hui,CHEN Zhi-gang,LU Jian-qi,DAI Xiao-hu,FU De-yu,MIAO Hua-wei,CHEN Ming,ZHOU Wei-dong,HAN Zu-cheng,YANG Dong-dong,WANG Zhen-tao,DU Ting-hai,YANG Xi-yan,CHEN Ying,ZHANG Yan,BAI Xue,XU Tao,XU Hao,WANG Yong-xi,WANG You-hu,WANG Qing-gao,CHU Yu-guang,HE Zhi-yi,TIAN Ying,LU Fang,YI Bo-wen.Experts consensus statement on Xinnaoning Capsule in clinical practice of atherosclerotic cardiovascular disease[J].Chinese Traditional and Herbal Drugs,2020,51(11):2863-2870. |
| |
| Authors: | LU Feng HU Yuan-hui CHEN Zhi-gang LU Jian-qi DAI Xiao-hu FU De-yu MIAO Hua-wei CHEN Ming ZHOU Wei-dong HAN Zu-cheng YANG Dong-dong WANG Zhen-tao DU Ting-hai YANG Xi-yan CHEN Ying ZHANG Yan BAI Xue XU Tao XU Hao WANG Yong-xi WANG You-hu WANG Qing-gao CHU Yu-guang HE Zhi-yi TIAN Ying LU Fang YI Bo-wen |
| |
| Affiliation: | Department of Cardiology of Affiliated Hospital of Shandong University of traditional Chinese Medicine, National Clinical Research Base of TCM, Jinan 250014, China;Guang''anmen Hospital, Chinese Academy of Traditional Chinese Medicine, Beijing 100053, China;Oriental Hospital of Beijing University of Traditional Chinese Medicine, Beijing 100078, China;The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning 530023, China;The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei 230031, China;Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China;Hebei Hospital of Traditional Chinese Medicine, Shijiazhuang 050011, China;The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China;Coal General Hospital, Beijing 100028, China;Shaanxi Traditional Chinese Medicine Hospital, Xi''an 710003, China;Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China;Henan Traditional Chinese Medicine Hospital, Zhengzhou 453003, China;The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450099, China;The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China;Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun 130021, China;Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China;Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University, Luzhou 646699, China;The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang 550003, China;Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine, Beijing 100091, China;Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200126, China;The First Affiliated Hospital of China Medical University, Shenyang 110122, China |
| |
| Abstract: | This consensus established the atherosclerotic process in the adult cardiovascular disease (atherosclerotic cardiovascular diseases, ASCVD) high-risk groups use of Xinnaoning capsule in order to enhance the curative effect of key process, summarized the compatibility theory of traditional Chinese medicine, the pharmaceutical and pharmacological research characteristics of Xinnaoning Capsule, defined the accurate applicable people, the intervention time and curative effect of disease characteristics and optimization solutions of Xinnaoning Capsule, summarized the adverse reactions, taboo, matters needing attention, and non-clinical safety and other relevant evidence of Xinnaoning Capsule. This consensus is suitable for practicing physicians, practicing physicians of traditional Chinese medicine, and practicing physicians of integrated traditional Chinese and Western medicine in ASCVD related professional fields. |
| |
| Keywords: | Xinnaoning Capsules atherosclerotic cardiovascular disease ASCVD qi stagnation and blood stasis syndrome moving qi and activating blood experts consensus statement |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《中草药》浏览原始摘要信息 |
|
点击此处可从《中草药》下载全文 |
|
